BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9012818)

  • 1. Activation of human B-MYB by cyclins.
    Sala A; Kundu M; Casella I; Engelhard A; Calabretta B; Grasso L; Paggi MG; Giordano A; Watson RJ; Khalili K; Peschle C
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):532-6. PubMed ID: 9012818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
    Lane S; Farlie P; Watson R
    Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.
    Lin D; Fiscella M; O'Connor PM; Jackman J; Chen M; Luo LL; Sala A; Travali S; Appella E; Mercer WE
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10079-83. PubMed ID: 7937841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1.
    Pilkinton M; Sandoval R; Song J; Ness SA; Colamonici OR
    J Biol Chem; 2007 Jan; 282(1):168-75. PubMed ID: 17098733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1, B-myb and selective members of cyclin/cdk subunits are targets for protein kinase C-mediated bimodal growth regulation in vascular endothelial cells.
    Zhou W; Takuwa N; Kumada M; Takuwa Y
    Biochem Biophys Res Commun; 1994 Feb; 199(1):191-8. PubMed ID: 8123011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
    Petrovas C; Jeay S; Lewis RE; Sonenshein GE
    Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-cycle regulation of B-Myb protein expression: specific phosphorylation during the S phase of the cell cycle.
    Robinson C; Light Y; Groves R; Mann D; Marias R; Watson R
    Oncogene; 1996 May; 12(9):1855-64. PubMed ID: 8649845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription regulation by murine B-myb is distinct from that by c-myb.
    Watson RJ; Robinson C; Lam EW
    Nucleic Acids Res; 1993 Jan; 21(2):267-72. PubMed ID: 8382794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of B-Myb activity by cyclin D1.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
    Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
    Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation.
    De Falco G; Bagella L; Claudio PP; De Luca A; Fu Y; Calabretta B; Sala A; Giordano A
    Oncogene; 2000 Jan; 19(3):373-9. PubMed ID: 10656684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter.
    Kamano H; Klempnauer KH
    Oncogene; 1997 Mar; 14(10):1223-9. PubMed ID: 9121772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells.
    Sala A; Casella I; Bellon T; Calabretta B; Watson RJ; Peschle C
    J Biol Chem; 1996 Apr; 271(16):9363-7. PubMed ID: 8621601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2Fs link the control of G1/S and G2/M transcription.
    Zhu W; Giangrande PH; Nevins JR
    EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M; Saville MK; Watson RJ
    Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
    Joaquin M; Bessa M; Saville MK; Watson RJ
    Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of B-Myb regulates its transactivation potential and DNA binding.
    Johnson TK; Schweppe RE; Septer J; Lewis RE
    J Biol Chem; 1999 Dec; 274(51):36741-9. PubMed ID: 10593981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.